Qualitative Platelet Disorders Flashcards
Group of disorders affecting the structure or function of platelets
Qualitative Platelet Disorders
Patients with this disorder usually will have an adequate number of platelets but poor “quality” of clotting.
Qualitative Platelet Disorders
Qualitative Platelet Disorders
Vascular Intima/Plasma
● Damaged Endothelium
● Exposed Collagen
● VWF
Platelet Adhesion
Platelets
● GPIb Complex
● GPIa/IIa , GPV
Bernard-Soulier Syndrome other name
Giant platelet syndrome
Inherited disorder in which the GP Ib/IX/V complex is missing from the platelet surface or exhibits abnormal function.
Bernard-Soulier Syndrome (Giant platelet syndrome)
Inability to bind to VWF accounts for the inability of platelets to adhere to exposed sub endothelium.
Bernard-Soulier Syndrome (Giant platelet syndrome)
Similar manifestation to Von Willebrand Disease.
Bernard-Soulier Syndrome (Giant platelet syndrome)
REMINDER ‼️‼️‼️‼️
BS Syndrome cannot be corrected by addition of normal plasma or Cryoprecipitate.
The GPIb-Complex receptor.
● Consist of the
GPIbα , GPIbβ , GPIX , GPV
GPIbα , GPIbβ , GPIX , GPV.
● These proteins are present in a ratio
2:2:2:1
The most frequent forms of BSS involves defects in
GPIbα
Antibody to GP Ib/V can cause
pseudo-BSS
Bernard-Soulier Syndrome (Giant platelet syndrome)
Variants
1.Normal surface expression of GPIb complex but impaired functionality.
2. Mutations that affect binding domains that cause poor binding.
3.Antibody to GP Ib/V can cause pseudo-BSS, causes a non- functional complex
Bernard-Soulier Syndrome
Laboratory features
Giant Platelets
appear larger compared to normal platelets on PBS due to a proposed tendency to spread into thin films on contact with glass.
Bernard-Soulier Syndrome
BSS
platelets are unusually large and fewer in number than usual (_________________)
Macrothrombocytopenia
Bernard-Soulier Syndrome
Laboratory features : Platelet aggregometry.
Macrothrombocytopenia and prolonged bleeding time.
Bernard-Soulier Syndrome (Giant platelet syndrome)
Treatment: treatment of choice
Platelet transfusion (must be leukoreduced to
reduce alloimmunization.)
Bernard-Soulier Syndrome (Giant platelet syndrome
REMINDER‼️‼️‼️‼️‼️
Antiplatelet therapy should be avoided
Bernard-Soulier Syndrome (Giant platelet syndrome)
Treatment: useful for mucosal bleeding.
Antifibrinolytic therapy
PLATELET AGGREGATION
PLASMA OR PLATELET GRANULES
● Ionized calcium
● Fibrinogen
PLATELET AGGREGATION
PLATELETS
● GPIIb/IIIa receptors
● ATP/ ADP
Glanzmann Thrombasthenia seen most frequently in populations______________________
high degree of consanguinity.
Deficiency or abnormality of the GPIIb/IIIa complex.
Glanzmann Thrombasthenia
GPIIb/IIIa complex complex is responsible for binding __________________
fibrinogen
vWF
fibronectin
other adhesive ligands.
Binding of GPIIb/IIIa complex to ____________ mediates the success of platelet aggregation.
Fibrinogen
0-5% of normal GPIIb/IIIa complex
Glanzmann Thrombasthenia
TYPE 1
10-20% of normal GPIIb/IIIa
Glanzmann Thrombasthenia
TYPE 2
Type of GT that is Less affected by abnormal clot
retraction
Glanzmann Thrombasthenia
TYPE 2
Glanzmann Thrombasthenia
Laboratory features:
● Normal platelet count and morphology.
● Abnormal aggregation. Prolonged bleeding time.
Glanzmann Thrombasthenia
Clinical Manifestations: Bleeding of all types;
Epistaxis , Ecchymosis, Hemarthrosis,
Subcutaneous hematoma, Menorrhagia and
GI / UT hemorrhage.
Glanzmann Thrombasthenia
Treatment: highly recommended
Platelet transfusion (leukoreduced)
Glanzmann Thrombasthenia
Treatment:
REMINDER‼️‼️‼️‼️‼️
Anticoagulant and antiplatelet agents should be avoided.
Glanzmann Thrombasthenia
Treatment: for menorrhagia
Hormonal therapy (Norethindrone acetate)
Release of Remaining Platelet granules to facilitate secondary wave of aggregation.
Platelet secretion
The most common of the hereditary defects are:
storage pool
release reaction defects